Oxford University said on Monday that vaccines are shown to induce lower levels of neutralising antibodies against the Omicron coronavirus variant, as reported by Reuters.
"Increasing vaccine uptake among unvaccinated, encouraging third doses, priority to reduce transmission levels, the potential for severe disease."
"Researchers used samples from study participants who got 2 doses of standard COVID-19 shots for neutralisation assays using Omicron virus isolate."
"Blood samples from individuals who had previously received two doses of Oxford-AstraZeneca or Pfizer-BioNTech vaccines were used."
"Pre-print results indicate omicron has the potential to drive a further wave of infections, including among those already vaccinated."
These remarks don't seem to be having a significant impact on market sentiment. As of writing, the UK's FTSE 100 Index was up 0.15% on a daily basis.
© 2000-2024. All rights reserved.
This site is managed by Teletrade D.J. LLC 2351 LLC 2022 (Euro House, Richmond Hill Road, Kingstown, VC0100, St. Vincent and the Grenadines).
The information on this website is for informational purposes only and does not constitute any investment advice.
The company does not serve or provide services to customers who are residents of the US, Canada, Iran, The Democratic People's Republic of Korea, Yemen and FATF blacklisted countries.
Making transactions on financial markets with marginal financial instruments opens up wide possibilities and allows investors who are willing to take risks to earn high profits, carrying a potentially high risk of losses at the same time. Therefore you should responsibly approach the issue of choosing the appropriate investment strategy, taking the available resources into account, before starting trading.
Use of the information: full or partial use of materials from this website must always be referenced to TeleTrade as the source of information. Use of the materials on the Internet must be accompanied by a hyperlink to teletrade.org. Automatic import of materials and information from this website is prohibited.
Please contact our PR department if you have any questions or need assistance at pr@teletrade.global.